{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_057173.4:c.6057G>A",
          "cDNA Change": {
            "transcript": "NM_057173.4",
            "ref": "G",
            "alt": "A",
            "position": "6057"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S variant"
        },
        {
          "HGVS": "NM_057173.4:c.4322G>T",
          "cDNA Change": {
            "transcript": "NM_057173.4",
            "ref": "G",
            "alt": "T",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005230"
  },
  "Experiment Method": [
    {
      "Assay Method": "Kinase activity assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with wild-type or mutant LRRK2 plasmids."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_057173.4:c.6057G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The G2019S variant increased LRRK2 kinase activity by 150% compared to wild-type."
        },
        {
          "Variant": "NM_057173.4:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The R1441C variant increased LRRK2 kinase activity by 120% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated in triplicate across three independent cell cultures."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was measured in duplicate using the kinase assay kit."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 plasmid was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 20% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity exceeding 150% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell viability assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with wild-type or mutant LRRK2 plasmids and monitored for viability."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_057173.4:c.6057G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Cell viability for G2019S variant was 95% compared to wild-type."
        },
        {
          "Variant": "NM_057173.4:c.4322G>T",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Cell viability for R1441C variant was 93% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated in triplicate across three independent cell cultures."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was measured in duplicate using the MTT assay."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 plasmid was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used for comparison between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability within 10% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability below 70% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunoblotting",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cell lysates were analyzed for LRRK2 protein expression."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_057173.4:c.6057G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The G2019S variant showed a 30% increase in LRRK2 protein levels."
        },
        {
          "Variant": "NM_057173.4:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The R1441C variant showed a 25% increase in LRRK2 protein levels."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated in triplicate across three independent cell cultures."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was measured in duplicate using Western blot with anti-LRRK2 antibody."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 plasmid was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression within 15% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression exceeding 30% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}